Olema Pharmaceuticals, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OLMA research report →
About the company
Olema Pharmaceuticals, Inc. , a biopharmaceutical enterprise in the clinical development stage, is dedicated to discovering, advancing, and commercializing therapeutic solutions for women's oncology. Headquartered in San Francisco, California, the company was established in 2006 and rebranded from CombiThera, Inc.
- CEO
- Sean Bohen
- IPO
- 2020
- Employees
- 96
- HQ
- San Francisco, CA, US
Price Chart
- Market Cap
- $1.10B
- P/E
- -6.26
- P/S
- 0.00
- P/B
- 2.70
- EV/EBITDA
- -5.70
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -45.95%
- ROIC
- -41.66%
- Revenue
- $0 · 0.00%
- Net Income
- $-162,451,000 · -25.47%
- EPS
- $-1.87 · 15.00%
- Op Income
- $-178,698,000
- FCF YoY
- -40.38%
- 52W High
- $36.26
- 52W Low
- $4.37
- 50D MA
- $12.62
- 200D MA
- $17.23
- Beta
- 2.01
- Avg Volume
- 1.38M
Get TickerSpark's AI analysis on OLMA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 18, 26 | BVF PARTNERS L P/IL | other | 29,500 |
| Jun 18, 26 | Harmon Cyrus | other | 29,500 |
| Jun 18, 26 | BUTITTA CYNTHIA M | other | 29,500 |
| Jun 18, 26 | Garland J. Scott | other | 29,500 |
| Jun 18, 26 | Hrustanovic Gorjan | other | 29,500 |
| Jun 18, 26 | CLARK IAN T | other | 29,500 |
| Jun 18, 26 | Larson Yi | other | 29,500 |
| Jun 18, 26 | Horning Sandra | other | 29,500 |
| Jun 18, 26 | Raman Prakash | other | 29,500 |
| Jun 18, 26 | RAPPAPORT ANDREW | other | 29,500 |
Our OLMA coverage
Recent articles, reports, and earnings notes.
No research on OLMA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OLMA report →Similar companies
Peers in the same neighborhood.